Skip to main content

Advertisement

Log in

PrP 106-126 Altered PrP mRNA gene expression in mouse microglia BV-2 Cells

  • Published:
Virologica Sinica

Abstract

Prion diseases are infectious and fatal neurodegenerative diseases. The pathogenic agent is an abnormal prion protein aggregate. Microglial activation in the centre nervous system is a characteristic feature of prion disease. In this study, we examined the effect of PrP 106–126 on PrP mRNA gene expression in Mouse microglia cells BV-2 by real-time quantitative PCR. PrP mRNA expression level was found to be significantly increased after 18 h exposure of BV-2 cells to PrP 106–126, with 3-fold increase after 18 h and 4.5-fold increase after 24 h and BV-2 cells proliferating occurred correspondingly. Our results provide the first in vitro evidence of the increase of PrP mRNA levels in microglial cells exposed to PrP 106–126, and indicate that microglial cells might play a critical role in prion pathogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aguzzi A, Heikenwalder M. 2006. Pathogenesis of prion diseases: current status and future outlook. Nature, 4: 765–775.

    CAS  Google Scholar 

  2. Baker C A, Lu Z Y, Zaitsev I,et al. 1999. Microglial Activation Varies in Different Models of Creutzfeldt-Jakob Disease. J Virol, 73(6): 5089–5097.

    CAS  PubMed  Google Scholar 

  3. Bai Y, Li Q, Yang J,et al. 2008. p75NTR activation of NF-κB is involved in PrP106-126-induced apoptosis in mouse neuroblastoma cells. Neuroscience Res, 662: 9–14.

    Article  CAS  Google Scholar 

  4. Barcikowska M, Liberski P P, Boellaard J W,et al. 1993. Microglia is a component of the prion protein amyloid plaque in the Gerstmann-Sträussler-Scheinker syndrome. Acta Neuropathol, 85: 623–627.

    Article  CAS  PubMed  Google Scholar 

  5. Biieler H, Aguzzi A, Sailer A,et al. 1993. Mice Devoid of PrP Are Resistant to Scrapie. Cell, 73: 1339–1347.

    Article  Google Scholar 

  6. Brandenburg L-O, Koch T, Sievers J,et al. 2007. Internalization of PrP106-126 by the formyl-peptidereceptorlike- 1 in glial cells. J Neurochem, 101: 718–728.

    Article  CAS  PubMed  Google Scholar 

  7. Brown D R, Schmidt B, Kretzschmar, H.A., 1996. Role of microglia and host protein in neurotoxicity of a prion protein fragment. Nature, 380: 345–347.

    Article  CAS  PubMed  Google Scholar 

  8. Brown H R, Goller N L, Rudelli RD,et al. 1990. The mRNA encoding the scrapie agent protein is present in a variety of non-neuronal cells. Acta Neuropathol, 80: 1–6.

    Article  CAS  PubMed  Google Scholar 

  9. Combs C K, Johnson D E, Cannady S B,et al. 1999. Identification of Microglial Signal Transduction Pathways Mediating a Neurotoxic Response to Amyloidogenic Fragments of b-Amyloid and Prion Proteins. J Neuroscience, 19: 928–939.

    CAS  Google Scholar 

  10. Forloni G, Angeretti N, Chiesa R,et al. 1993. Neurotoxicity of a prion protein fragment. Nature, 362: 543–546.

    Article  CAS  PubMed  Google Scholar 

  11. Giese A, Brown D R, Groschup M H,et al. 2006. Role of Microglia in Neuronal Cell Death in Prion Disease. Brain Pathol, 8(3): 449–457.

    Article  Google Scholar 

  12. Mchattie S J, Brown D R, Bird M M, 2004. Uptake of the prion protein fragment PrP106-126 in vitro. J Neurocytol, 28: 149–159.

    Article  Google Scholar 

  13. Moser M, Colello R J, Pott U,et al. 1995. Developmental Expression of the Prion Protein Gene in Glial Cells. Neuron, 14: 509–517.

    Article  CAS  PubMed  Google Scholar 

  14. Muhleisen H, Gehrmann J, Meyermann R. 1995. Reactive microgIia in Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol, 21(6): 505–517.

    Article  CAS  PubMed  Google Scholar 

  15. Sileia V, Fabrizia C, Venturini G,et al. 1999. Activation of microglial cells by PrP and β-amyloid fragments raises intracellular calcium through L-type voltage sensitive calcium channels. Brain Res, 8818: 168–170.

    Article  Google Scholar 

  16. Tagliavini F, Prelli F, Verga L,et al. 1993. Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. Proc Natl Acad Sci USA, 90: 9678–9682.

    Article  CAS  PubMed  Google Scholar 

  17. Prusiner S B. 1997. Prion Diseases and the BSE Crisis. Science, 278: 245–251.

    Article  CAS  PubMed  Google Scholar 

  18. Prusiner S B. 1998. Prions. Proc. Natl. Acad. Sci USA, 95: 13363–13383.

    Article  CAS  PubMed  Google Scholar 

  19. Prusiner S B. 2001. Neurodegenerative Diseases and Prions. N Engl J Med, 344(20): 1516–1526.

    Article  CAS  PubMed  Google Scholar 

  20. Prusiner S B, Groth D, Serban A,et al. 1993. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci USA, 90: 10608–10612.

    Article  CAS  PubMed  Google Scholar 

  21. Williamsa A, Lucassenc P J, Ritchiea D,et al. 1997. PrP Deposition, Microglial Activation, and Neuronal Apoptosis in Murine Scrapie. Exp Neurol, 144: 433–438.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to De-ming Zhao.

Additional information

Foundation items: National Natural Science Foundations of China (30871854); National Science and Technology Supporting Program of China (2006BAD06A13).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bai, Y., Li, Yr., Wang, Gh. et al. PrP 106-126 Altered PrP mRNA gene expression in mouse microglia BV-2 Cells. Virol. Sin. 25, 440–444 (2010). https://doi.org/10.1007/s12250-010-3143-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12250-010-3143-z

Key words

Navigation